ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts ...

The design for a medical study in 1743 that was never carried out may have inspired James Lind’s groundbreaking clinical ...

Fiduciary Management Inc. (FMI), an independent money management firm, released its “FMI International Equity Strategy ...

Quoin Pharmaceuticals (QNRX) announces interim clinical data from its ongoing Investigator Pediatric Netherton Syndrome clinical study. The ...

GeoVax Labs (GOVX) announced significant progress in advancing Gedeptin as a cancer therapy. Gedeptin, based on a Gene-Directed Enzyme Prodrug ...

ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research ...

At Mayo Clinic, the needs of the patient come first. Part of this commitment involves conducting medical research with the goal of helping patients live longer, healthier lives. Through clinical ...

Royal Bank of Canada reissued their outperform rating on shares of ICON Public (NASDAQ:ICLR – Free Report) in a research report report published on Wednesday morning,Benzinga reports. Royal Bank of ...

ICON Public (NASDAQ:ICLR – Get Free Report)‘s stock had its “outperform” rating reissued by William Blair in a research note ...

With more than 30 years in life sciences and 15 years leading CRO Business Development efforts, Gross will spearhead the next ...

A body weight-adjusted regimen of Uptravi dosing for children and adolescents with PAH was deemed appropriate, according to a ...